BioStock: Full phase II results of uPAR-PET in glioblastoma published

Curasight has published the full data from an investigator-initiated phase II trial evaluating its uTRACE imaging technology in brain cancer patients in the peer-reviewed journal EJNMMI Research. The results – which were first reported in connection with an oral presentation at a conference last year – supports the strategy to develop uTRACE and the therapeutic uTREAT in parallel.

Read the full article at biostock.se:

https://www.biostock.se/en/2024/11/full-phase-ii-results-of-upar-pet-in-glioblastoma-published/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se